Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00040040

Enrollment

Registered

2002-06-18

Start date

2002-06-30

Completion date

2003-09-30

Last updated

2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amphetamine-Related Disorders

Brief summary

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

Detailed description

This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.

Interventions

DRUGBupropion

Study design

Allocation

RANDOMIZED

Primary purpose

DIAGNOSTIC

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

Please contact site director for more details.

Exclusion criteria

Please contact site director for more details.

Design outcomes

Primary

Measure	Time frame
Psychological effects	—
BP, HR	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026